| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Correspondence |
Hôpital Maisonneuve-Rosemont, Montréal, Canada, E-mail: francois.donati{at}umontreal.ca
To the Editor:
I read with great interest the article by Yang et al.1 describing differences in postoperative nausea and vomiting between sevoflurane-remifentanil and propofol-fentanyl-rocuronium induction methods. The authors also evaluated intubating conditions according to a system (Table
) proposed by experts in neuromuscular pharmacology at a consensus conference held in Denmark in 1994 and published as an article entitled: "Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents".2 Although the article has been quoted widely, its recommendations have not always been followed and important variations have been introduced.
|
Even with careful evaluation, assessment of intubating conditions remains qualitative and relatively inaccurate. Three possible results (excellent, good and poor), with the addition of a fourth (impossible), are probably enough. There is no need to introduce a system that allows 13 possible results (012, or 113 as in Figure 1).1 In addition, the GCRP recommendations are widely accepted, and comparisons can be made more easily between studies. The data provided by Yang et al.1 would be more easily interpretable if they had reported the results as excellent, good or poor.
References
1 Yang H, Choi PT, McChesney J, Buckley N. Induction with sevoflurane-remifentanil is comparable to propofol-fentanyl-rocuronium in PONV after laparoscopic surgery. Can J Anesth 2004; 51: 6607.
2 Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular agents. Acta Anaesthesiol Scand 1996; 40: 5974.[Medline]
Related articles in CJA:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |